Risk factors for non-participation in a universal developmental surveillance program in a population in Australia.


Journal

Australian health review : a publication of the Australian Hospital Association
ISSN: 1449-8944
Titre abrégé: Aust Health Rev
Pays: Australia
ID NLM: 8214381

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 18 01 2019
accepted: 09 05 2019
pubmed: 1 8 2020
medline: 25 6 2021
entrez: 1 8 2020
Statut: ppublish

Résumé

Objectives This study examined the risk factors for non-participation in a developmental surveillance program in a population in south-west Sydney with a high proportion of culturally diverse and socioeconomically disadvantaged people. Methods Data from 850 and 625 12- and 18-month-old children respectively from the Watch Me Grow (WMG) birth cohort were used for this study. Logistic regression models were used to assess risk factors for 12- and 18-month non-attendance at Well Child Visits, as well as non-completion of the developmental surveillance questionnaire Parents' Evaluation of Developmental Status (PEDS) in the child's personal health record (PHR). Results Independent risk factors for non-attendance at Well Child Visits were female sex of the child (odds ratio (OR) 12 months 1.5; 95% confidence interval (CI) 1.0-2.3), mother's country of birth Australia (OR 18 months 1.8; 95% CI 1.2-2.7), annual household income less than A$25001 (OR 12 months 1.8; 95% CI 1.0-3.2) and residing in a socioeconomically disadvantaged neighbourhood (OR 12 months 1.7; 95% CI 1.1-2.5). Independent risk factors for non-completion of PEDS in those who did not attend the Well Child Visit compared with those who did attend and did complete PEDS were household annual income at birth less than A$25001 (OR 12 months 3.9; 95% CI 1.9-8.1) and residing in a socioeconomically disadvantaged neighbourhood (OR 12 months 2.1 (95% CI 1.2-3.7) and OR 18 months 2.0 (95% CI 1.2-3.6)). Conclusions In this population, children exposed to socioeconomic disadvantage are less likely to have attended a Well Child Visit and to have a completed PEDS in their PHR at 12 and/or 18 months of age. What is known about the topic? Developmental problems are common in early childhood, and children from socioeconomically disadvantaged households are at higher risk. Universal developmental surveillance programs may be effective at early identification of children at risk of developmental problems. Early childhood interventions, when accessed, can lessen the effects of developmental problems in later years. What does this paper add? This paper highlights that children exposed to socioeconomic disadvantage in early childhood who are at higher risk of having developmental problems are also at higher risk of missing out on early identification by non-participation in universal developmental surveillance. What are the implications for practitioners? A more equitable model of developmental surveillance should include a framework of proportionate universalism to ensure optimal engagement of high-risk population groups.

Identifiants

pubmed: 32731919
pii: AH18236
doi: 10.1071/AH18236
doi:

Types de publication

Journal Article

Langues

eng

Pagination

512-520

Auteurs

Chandra Ayer (C)

Royal Far West, PO Box 52, Manly, NSW 1655, Australia; and Kogarah Diagnostic Assessment Service, St George Hospital, 90 Railway Parade, Kogarah, NSW 2217, Australia; and Corresponding author. Email: chandraa@royalfarwest.org.au.

Valsamma Eapen (V)

Psychiatry Research and Teaching Unit, School of Psychiatry, UNSW, Level 1, Mental Health Centre, Liverpool Hospital, corner Forbes and Campbell Streets, Liverpool, NSW 2170, Australia. Email: v.eapen@unsw.edu.au; and Academic Unit of Child Psychiatry, Ingham Institute of Applied Medical Research, PO Box 3151 (Westfields), Liverpool, NSW 2170, Australia; and South Western Sydney Clinical School, Faculty of Medicine, UNSW, Liverpool Hospital, Liverpool, NSW 2170, Australia.

Bronwyn Overs (B)

NeuRA, PO Box 1165, Randwick, NSW 2031, Australia. Email: bronwyn.overs@gmail.com.

Joseph Descallar (J)

South Western Sydney Clinical School, Faculty of Medicine, UNSW, Liverpool Hospital, Liverpool, NSW 2170, Australia; and Ingham Institute of Applied Medical Research, PO Box 3151 (Westfields), Liverpool, NSW 2170, Australia. Email: joseph.descallar@sswahs.nsw.gov.au; b.jalaludin@unsw.edu.au.

Bin Jalaludin (B)

Ingham Institute of Applied Medical Research, PO Box 3151 (Westfields), Liverpool, NSW 2170, Australia. Email: joseph.descallar@sswahs.nsw.gov.au; b.jalaludin@unsw.edu.au; and School of Public Health and Community Medicine, UNSW, Sydney, NSW 2052, Australia.

John Graeme Eastwood (JG)

Ingham Institute of Applied Medical Research, PO Box 3151 (Westfields), Liverpool, NSW 2170, Australia. Email: joseph.descallar@sswahs.nsw.gov.au; b.jalaludin@unsw.edu.au; and Community Paediatrics, Sydney Local Health District, Level 11 KGV Building, Missenden Road, Camperdown, NSW 2050, Australia. Email: j.eastwood@unsw.edu.au; and School of Public Health, Menzies Centre for Health Policy, University of Sydney, Edward Ford Building, A27 Fisher Road, Sydney, NSW 2006, Australia; and School of Medicine, Griffith University, Parklands Drive, Southport, Gold Coast, Qld 4222, Australia; and School of Women's and Children's Health, UNSW, Sydney, NSW 2052, Australia.

Cheryl Dissanayake (C)

Olga Tennison Autism Research Centre, La Trobe University, Kingsbury Drive, Bundoora, Vic. 3083, Australia. Email: c.dissanayake@latrobe.edu.au.

Katrina Williams (K)

Department of Paediatrics, Melbourne Medical School, The University of Melbourne, Melbourne, Vic. 3010, Australia; and Present address: Department of Paediatrics, Monash University, School of Clinical Sciences, Level 5, Monash Children's Hospital, 246 Clayton Road, Clayton, Vic. 3168, Australia. Email: Katrina.Williams@monash.edu.

Elisabeth Murphy (E)

NSW Ministry of Health, Child, Youth and Family Health Services, PO Box 4007, Royal North Shore LPO, St Leonards, NSW 2065, Australia. Email: lmurp@doh.health.nsw.gov.au.

Susan Woolfenden (S)

School of Women's and Children's Health, UNSW, Sydney, NSW 2052, Australia; and Department of Community Paediatrics, Sydney Children's Hospital Network, High Street, Randwick, NSW 2031, Australia. Email: susan.woolfenden@health.nsw.gov.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH